FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christian Peschel

Research Profile

Living Beings

Mouse

Disorders

Anatomy

Chemicals & Drugs

Procedures

Antineoplastic Combined Chemotherapy Protocols

Physiology

Phenomena

Phosphorylation

Co-author Network

Publications

TOP 3
Angela Ihbe-Heffinger; B Paessens; Karin Berger; R Bernard; M Shlaen; Christoph von Schilling; Christian Peschel
The impact of chemotherapy-induced side effects on medical care usage and cost in German hospital care--an observational analysis on non-small-cell lung cancer patients.
Katrin Schweneker; Marc Schweneker; Jürg Tschopp; Oliver Gorka; Christian Peschel; Hendrik Poeck; Jürgen Ruland; Olaf Gross
The mycobacterial cord factor adjuvant analogue trehalose-6,6'-dibehenate (TDB) activates the Nlrp3 inflammasome.
Gloria Lutzny; Robert Oostendorp; Christian Peschel; Jan Dürig; Alexander Egle; Andrew J Finch; Claudia Haferlach; Ludger Klein-Hitpass; Thomas Kocher; Alexander Kohlmann; Toni Kuhnt; Benedikt Lampl; Michael Leitges; Martina Rudelius; Jürgen Ruland; Yvonne Schäfer; Marc Schmidt-Supprian; Susanne Schnittger; Marc Seifert; Michaela Wagner; Stefan Wanninger; Nadja Zaborsky; Ingo Ringshausen
Protein kinase c-β-dependent activation of NF-κB in stromal cells is indispensable for the survival of chronic lymphocytic leukemia B cells in vivo.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christian Peschel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Angela Ihbe-Heffinger; B Paessens; Karin Berger; R Bernard; M Shlaen; Christoph von Schilling; Christian Peschel
The impact of chemotherapy-induced side effects on medical care usage and cost in German hospital care--an observational analysis on non-small-cell lung cancer patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2013;21(6):1665-75.
2013: Katrin Schweneker; Marc Schweneker; Jürg Tschopp; Oliver Gorka; Christian Peschel; Hendrik Poeck; Jürgen Ruland; Olaf Gross
The mycobacterial cord factor adjuvant analogue trehalose-6,6'-dibehenate (TDB) activates the Nlrp3 inflammasome.
Immunobiology 2013;218(4):664-73.
2013: Gloria Lutzny; Robert Oostendorp; Christian Peschel; Jan Dürig; Alexander Egle; Andrew J Finch; Claudia Haferlach; Ludger Klein-Hitpass; Thomas Kocher; Alexander Kohlmann; Toni Kuhnt; Benedikt Lampl; Michael Leitges; Martina Rudelius; Jürgen Ruland; Yvonne Schäfer; Marc Schmidt-Supprian; Susanne Schnittger; Marc Seifert; Michaela Wagner; Stefan Wanninger; Nadja Zaborsky; Ingo Ringshausen
Protein kinase c-β-dependent activation of NF-κB in stromal cells is indispensable for the survival of chronic lymphocytic leukemia B cells in vivo.
Cancer cell 2013;23(1):77-92.
2013: Vanesa Fernández-Sáiz; Anna-Maria Knorn; Julia Kurutz; Bernhard Kuster; Christian Langer; Simone Lemeer; Michele Pagano; Christian Peschel; Clemens Reiter; Sonja Schroeder; Julia Slotta-Huspenina; Bianca-Sabrina Targosz; Lars Bullinger; Ruth Eichner; Florian Bassermann
SCFFbxo9 and CK2 direct the cellular response to growth factor withdrawal via Tel2/Tti1 degradation and promote survival in multiple myeloma.
Nature cell biology 2013;15(1):72-81.
2013: Nicolas Graf; Ken Herrmann; Ulrich Keller; Barbara Numberger; Christian Peschel; Tibor Schuster; Markus Schwaiger; Reingard Senekowitsch-Schmidtke; Hans-Jürgen Wester; Daniela Zwisler; Michaela Aichler; Tobias Dechow; Annette Feuchtinger; Andreas K Buck
[18F]FLT is superior to [18F]FDG for predicting early response to antiproliferative treatment in high-grade lymphoma in a dose-dependent manner.
European journal of nuclear medicine and molecular imaging 2013;40(1):34-43.
2013: Ruth Eichner; Markus Essler; Christian Peschel; Ingo Ringshausen; Martina Rudelius; Klaus Wörtler; K Götze
Symmetric multifocal bone marrow involvement diagnosed by whole-body magnetic resonance imaging in a patient with B lymphoblastic lymphoma.
Annals of hematology 2013;92(2):277-8.
2012: Anna Lena Illert; Stefanie Kreutmair; Cathrin Moll; Christian Peschel; Michael Zech; Corinna Albers; Florian Bassermann; Justus Duyster
Extracellular signal-regulated kinase 2 (ERK2) mediates phosphorylation and inactivation of nuclear interaction partner of anaplastic lymphoma kinase (NIPA) at G2/M.
The Journal of biological chemistry 2012;287(45):37997-8005.
2012: Luise Ullrike Weigand; K Götze; Richard Klar; Xiaoling Liang; Sabine Mall; Josef Mautner; Christian Peschel; Christoph Salat; Sabine Schmied; Oliver J Stötzer; Angela M Krackhardt
Isolation of human MHC class II-restricted T cell receptors from the autologous T-cell repertoire with potent anti-leukaemic reactivity.
Immunology 2012;137(3):226-38.
2012: Thomas Decker; Gerhard Fischer; Philipp Bücke; Wolfgang Bücke; Martina Gropp-Meier; Andreas Grüneberger; Christian Peschel; Christine Pfeiffer; Frank Stotz; Günther Wiedemann; K Götze
Increased number of regulatory T cells (T-regs) in the peripheral blood of patients with Her-2/neu-positive early breast cancer.
Journal of cancer research and clinical oncology 2012;138(11):1945-50.
2012: Zhoulei Li; Christian Peschel; Markus Schwaiger; Axel Walch; Michaela Aichler; Anja Baumgart; Andreas Buck; Annette Feuchtinger; Nicolas Graf; Ken Herrmann; Alexandra Jünger; Ulrich Keller; Tobias Dechow
FLT-PET is superior to FDG-PET for very early response prediction in NPM-ALK-positive lymphoma treated with targeted therapy.
Cancer research 2012;72(19):5014-24.
2012: Anna Lena Illert; Hiroyuki Kawaguchi; Stephan W Morris; Christian Peschel; Letitia Quintanilla-Martinez; Christine von Klitzing; Cristina Antinozzi; Marco Barchi; Florian Bassermann; Dirk G de Rooij; Mitsuteru Hiwatari; Justus Duyster
Targeted inactivation of nuclear interaction partner of ALK disrupts meiotic prophase.
Development (Cambridge, England) 2012;139(14):2523-34.
2012: Alexander Hoellein; Gabriele Hölzlwimmer; Florian Bassermann; Steffi Graf; Monika Kröger; Robert Oostendorp; Christian Peschel; Ulrich Platz; Leticia Quintanilla-Fend; Stephanie Schoeffmann; Ulrich Keller
Cks1 promotion of S phase entry and proliferation is independent of p27Kip1 suppression.
Molecular and cellular biology 2012;32(13):2416-27.
2012: Holger Krönig; Dieter Muck; Marcus Odendahl; Christian Peschel; Stephan Schulz; Christian Blank; Bettina Brackertz; Heinke Conrad; Bernhard Haller; Rüdiger Hein; Kathrin Julia Falchner; Helga Bernhard
PD-1 expression on Melan-A-reactive T cells increases during progression to metastatic disease.
International journal of cancer. Journal international du cancer 2012;130(10):2327-36.
2012: Viola Biberacher; Christian Bogner; Thomas Decker; Robert J Kreitman; Christian Meyer Zum Büschenfelde; Madlene Oelsner; Ira Pastan; Christian Peschel; Burkhard Schmidt; Michaela Wagner; Ingo Ringshausen
The cytotoxicity of anti-CD22 immunotoxin is enhanced by bryostatin 1 in B-cell lymphomas through CD22 upregulation and PKC-βII depletion.
Haematologica 2012;97(5):771-9.
2012: Bernadette Paessens; Christian Peschel; Wolfgang Schramm; Rita Shlaen; Christoph von Schilling; Rudolf Bernard; Angela Ihbe-Heffinger; Karin Berger
Blood component use and associated costs after standard dose chemotherapy--a prospective analysis of routine hospital care in lymphoproliferative disorders and NSCLC in Germany.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2012;20(5):1011-21.
2012: Hannes Leischner; Christian Peschel; Elena Razumovskaya; Lars Rönnstrand; Karsten Spiekermann; Corinna Albers; Stefan Bohlander; K Götze; Rebekka Grundler; Justus Duyster
SRC is a signaling mediator in FLT3-ITD- but not in FLT3-TKD-positive AML.
Blood 2012;119(17):4026-33.
2012: Helge Menzel; Christian Peschel; Tibor Schuster; Hans-Jochem Kolb; Tobias Dechow; Katarzyna Hinmüller; Alexander Hoellein; Ulrich Keller
Efficacy of repeat myeloablative chemotherapy with autologous stem-cell support in multiple myeloma.
Therapeutic advances in hematology 2012;3(2):81-8.
2012: Susanne Kratzat; Cornelius Miething; Viktoriya Nikolova; Jonas Nilsson; Christian Peschel; Elke Pietschmann; Jürgen Ruland; Stephanie Schoeffmann; Justus Duyster; Oliver Gorka; Alexander Hoellein; Anna-Lena Illert; Ulrich Keller
Cks1 is required for tumor cell proliferation but not sufficient to induce hematopoietic malignancies.
PloS one 2012;7(5):e37433.
2011: Ken Herrmann; Andreas K Buck; Tobias Dechow; Nicolas Graf; Christian Peschel; Martina Rudelius; Christine Scheuerer; Tibor Schuster; Markus Schwaiger; Hans-Jürgen Wester; Ulrich Keller
A pilot study to evaluate 3'-deoxy-3'-18F-fluorothymidine pet for initial and early response imaging in mantle cell lymphoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(12):1898-902.
2011: B J Paessens; Christian Peschel; M Shlaen; Christoph von Schilling; K Berger; R Bernard; C Müller-Thomas; Angela Ihbe-Heffinger
Health resource consumption and costs attributable to chemotherapy-induced toxicity in German routine hospital care in lymphoproliferative disorder and NSCLC patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(10):2310-9.
2011: Rouzanna Istvanffy; Ulrich B Keller; Monika Kröger; Franziska Bock; Christina Eckl; Sylke Gitzelmann; Steffi Graf; Christian Peschel; Matthias Schiemann; Baiba Vilne; Robert A J Oostendorp
Stromal pleiotrophin regulates repopulation behavior of hematopoietic stem cells.
Blood 2011;118(10):2712-22.
2011: Corinna Albers; Anna L Illert; Hannes Leischner; Cornelius Miething; Christian Peschel; Melanie Thiede; Justus Duyster
An RNAi-based system for loss-of-function analysis identifies Raf1 as a crucial mediator of BCR-ABL-driven leukemogenesis.
Blood 2011;118(8):2200-10.
2011: Alexander Hoellein; Anja Baumgart; Henning Bier; Tobias Dechow; Christian Peschel; Anja Pickhard; Guido Piontek; Martina Rudelius; Stephanie Schoeffmann; Fabienne von Keitz; Stefan Wagenpfeil; Ulrich Keller
Aurora kinase inhibition overcomes cetuximab resistance in squamous cell cancer of the head and neck.
Oncotarget 2011;2(8):599-609.
2011: Christian Meyer zum Büschenfelde; Karin Becker; Matthias Ebert; Helmut Friess; Hans Geinitz; Ken Herrmann; Rupert Langer; Florian Lordick; Katja Ott; Christian Peschel; Tibor Schuster; Markus Schwaiger; Frank Zimmermann; Bernd Joachim Krause
(18)F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(8):1189-96.
2011: S Huber; Madlene Oelsner; Thomas Decker; C Meyer zum Büschenfelde; M Wagner; G Lutzny; T Kuhnt; B Schmidt; R A J Oostendorp; Christian Peschel; Ingo Ringshausen
Sorafenib induces cell death in chronic lymphocytic leukemia by translational downregulation of Mcl-1.
Leukemia 2011;25(5):838-47.
2011: Nikolas von Bubnoff; S P Gorantla; R A Engh; T M Oliveira; S Thöne; E Aberg; Christian Peschel; Justus Duyster
The low frequency of clinical resistance to PDGFR inhibitors in myeloid neoplasms with abnormalities of PDGFRA might be related to the limited repertoire of possible PDGFRA kinase domain mutations in vitro.
Oncogene 2011;30(8):933-43.
2011: Rama Krishna Kancha; Christian Peschel; Justus Duyster
The epidermal growth factor receptor-L861Q mutation increases kinase activity without leading to enhanced sensitivity toward epidermal growth factor receptor kinase inhibitors.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(2):387-92.
2011: Rama Krishna Kancha; Christian Peschel; Nikolas von Bubnoff; Natalie Bartosch; Richard A Engh; Justus Duyster
Differential sensitivity of ERBB2 kinase domain mutations towards lapatinib.
PloS one 2011;6(10):e26760.
2011: Angela Ihbe-Heffinger; Bernadette J Paessens; Christoph von Schilling; Margarita Shlaen; Nina Gottschalk; Karin Berger; Rudolf Bernard; Marion Kiechle; Christian Peschel; Volker R Jacobs
Management of febrile neutropenia--a German prospective hospital cost analysis in lymphoproliferative disorders, non-small cell lung cancer, and primary breast cancer.
Onkologie 2011;34(5):241-6.
2010: Sivahari P Gorantla; Tobias N Dechow; Rebekka Grundler; Anna Lena Illert; Christian Meyer zum Büschenfelde; Marcus Kremer; Christian Peschel; Justus Duyster
Oncogenic JAK2V617F requires an intact SH2-like domain for constitutive activation and induction of a myeloproliferative disease in mice.
Blood 2010;116(22):4600-11.
2010: Thomas Decker; Christian Bogner; Madlene Oelsner; Christian Peschel; Ingo Ringshausen
Antiapoptotic effect of interleukin-2 (IL-2) in B-CLL cells with low and high affinity IL-2 receptors.
Annals of hematology 2010;89(11):1125-32.
2010: Nikolas Kaltz; Jochen Ringe; Christina Holzwarth; Pierre Charbord; Markus Niemeyer; Volker R Jacobs; Christian Peschel; Thomas Häupl; Robert A J Oostendorp
Novel markers of mesenchymal stem cells defined by genome-wide gene expression analysis of stromal cells from different sources.
Experimental cell research 2010;316(16):2609-17.
2010: Jürgen den Hollander; Sara Rimpi; Joanne R Doherty; Martina Rudelius; Andreas Buck; Alexander Hoellein; Marcus Kremer; Nikolas Graf; Markus Scheerer; Mark A Hall; Andrei Goga; Nikolas von Bubnoff; Justus Duyster; Christian Peschel; John L Cleveland; Jonas A Nilsson; Ulrich Keller
Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state.
Blood 2010;116(9):1498-505.
2010: Nikolas von Bubnoff; C Rummelt; H Menzel; M Sigl; Christian Peschel; Justus Duyster
Identification of a secondary FLT3/A848P mutation in a patient with FLT3-ITD-positive blast phase CMML and response to sunitinib and sorafenib.
Leukemia 2010;24(8):1523-5.
2010: Ingo Ringshausen; Yvonne Feuerstacke; Philipp Krainz; Jürgen den Hollander; Ken Hermann; Andreas Buck; Christian Peschel; Christian Meyer Zum Bueschenfelde
Antifungal therapy with itraconazole impairs the anti-lymphoma effects of rituximab by inhibiting recruitment of CD20 to cell surface lipid rafts.
Cancer research 2010;70(11):4292-6.
2010: Konstanze Pechloff; Julian Holch; Uta Ferch; Marc Schweneker; Kristina Brunner; Markus Kremer; Tim D. Sparwasser; Leticia Quintanilla-Martinez; Ursula Zimber-Strobl; Berthold Streubel; Andreas Gewies; Christian Peschel; Jürgen Ruland
The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma.
The Journal of experimental medicine 2010;207(5):1031-44.
2010: Ulrich Keller; Nikolas von Bubnoff; Christian Peschel; Justus Duyster
Oncologist's/haematologist's view on the roles of pathologists for molecular targeted cancer therapy.
Journal of cellular and molecular medicine 2010;14(4):805-17.
2010: Jonas Renström; Monika Kröger; Christian Peschel; Robert A J Oostendorp
How the niche regulates hematopoietic stem cells.
Chemico-biological interactions 2010;184(1-2):7-15.
2010: Jennifer B Old; Susanne Kratzat; Alexander Hoellein; Steffi Graf; Jonas A Nilsson; Lisa Nilsson; Keiichi I Nakayama; Christian Peschel; John L Cleveland; Ulrich B Keller
Skp2 directs Myc-mediated suppression of p27Kip1 yet has modest effects on Myc-driven lymphomagenesis.
Molecular cancer research : MCR 2010;8(3):353-62.
2010: Philipp Fischer; Marc Rümmler; Christian Schulz; Christian Peschel; Ilka Ott; Robert A J Oostendorp
Altered adhesive properties of cord blood endothelial outgrowth cells expressing IL-1ra.
Immunology and cell biology 2010;88(3):313-20.
2010: Alexander Hoellein; Thomas Decker; Christian Bogner; Madlen Oelsner; Stefanie Hauswald; Christian Peschel; Ulrich Keller; Thomas Licht
Expression of multidrug resistance-associated ABC transporters in B-CLL is independent of ZAP70 status.
Journal of cancer research and clinical oncology 2010;136(3):403-10.
2010: Florian Lordick; Birgit Luber; Sylvie Lorenzen; S Hegewisch-Becker; G Folprecht; E Wöll; T Decker; Esther Endlicher; N Röthling; T Schuster; Gisela Keller; Falko Fend; Christian Peschel
Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
British journal of cancer 2010;102(3):500-5.
2010: Mareike Verbeek; Falko Fend; Thomas Licht; Christian Meyer zum Büschenfelde; Jens Stollfuss; Christian Peschel; Justus Duyster
T-cell lymphoproliferative disorder potentially induced by imatinib in a patient with GIST.
Nature reviews. Clinical oncology 2010;7(2):116-9.
2010: Ulrich Keller; Jürgen Huber; Jonas A Nilsson; Mohammad Fallahi; Mark A Hall; Christian Peschel; John L Cleveland
Myc suppression of Nfkb2 accelerates lymphomagenesis.
BMC cancer 2010;10():348.
2010: Hendrik Poeck; Michael Bscheider; Olaf Gross; Katrin Finger; Susanne Roth; Manuele Rebsamen; Nicole Hannesschläger; Martin Schlee; Simon Rothenfusser; Winfried Barchet; Hiroki Kato; Shizuo Akira; Satoshi Inoue; Stefan Endres; Christian Peschel; Gunther Hartmann; Veit Hornung; Jürgen Ruland
Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production.
Nature immunology 2010;11(1):63-9.
2010: C Meyer zum Büschenfelde; M Wagner; G Lutzny; Madlene Oelsner; Y Feuerstacke; Thomas Decker; Christian Bogner; Christian Peschel; Ingo Ringshausen
Recruitment of PKC-betaII to lipid rafts mediates apoptosis-resistance in chronic lymphocytic leukemia expressing ZAP-70.
Leukemia 2010;24(1):141-52.
2010: Christian Bogner; Tobias Dechow; Ingo Ringshausen; Michaela Wagner; Madlene Oelsner; Gloria Lutzny; Thomas Licht; Christian Peschel; Ira Pastan; Robert J Kreitman; Thomas Decker
Immunotoxin BL22 induces apoptosis in mantle cell lymphoma (MCL) cells dependent on Bcl-2 expression.
British journal of haematology 2010;148(1):99-109.
2009: Joerg Theisen; Bernd Krause; Christian Peschel; Roland Schmid; Hans Geinitz; Helmut Friess
Early response evaluation and prediction in neoadjuvant-treated patients with esophageal cancer.
World journal of gastrointestinal surgery 2009;1(1):30-7.
2009: Uta Ferch; Bernhard Kloo; Andreas Gewies; Vera Pfänder; Michael Düwel; Christian Peschel; Daniel Krappmann; Jürgen Ruland
Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells.
The Journal of experimental medicine 2009;206(11):2313-20.
2009: Sylvie Lorenzen; T Schuster; R Porschen; S-E Al-Batran; Ralf-Dieter Hofheinz; P Thuss-Patience; M Moehler; P Grabowski; D Arnold; Tim F Greten; L Müller; N Röthling; Christian Peschel; Rupert Langer; Florian Lordick
Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(10):1667-73.
2009: Jonas Renström; Rouzanna Istvanffy; Kerstin Gauthier; Akihiko Shimono; Jörg Mages; Ana Jardon-Alvarez; Monika Kröger; Matthias Schiemann; Dirk H Busch; Irene Esposito; Roland Lang; Christian Peschel; Robert A J Oostendorp
Secreted frizzled-related protein 1 extrinsically regulates cycling activity and maintenance of hematopoietic stem cells.
Cell stem cell 2009;5(2):157-67.
2009: Holger Krönig; Kathrin Hofer; Heinke Conrad; Philippe Guilaume; Julia Müller; Matthias Schiemann; Volker Lennerz; Antonio Cosma; Christian Peschel; Dirk H Busch; Pedro Romero; Helga Bernhard
Allorestricted T lymphocytes with a high avidity T-cell receptor towards NY-ESO-1 have potent anti-tumor activity.
International journal of cancer. Journal international du cancer 2009;125(3):649-55.
2009: Stefanie Hauswald; Jesus Duque-Afonso; Michaela M Wagner; Florian M Schertl; Michael Lübbert; Christian Peschel; Ulrich Keller; Thomas Licht
Histone deacetylase inhibitors induce a very broad, pleiotropic anticancer drug resistance phenotype in acute myeloid leukemia cells by modulation of multiple ABC transporter genes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(11):3705-15.
2009: Nikolas von Bubnoff; Richard A Engh; Espen Aberg; Jana Sänger; Christian Peschel; Justus Duyster
FMS-like tyrosine kinase 3-internal tandem duplication tyrosine kinase inhibitors display a nonoverlapping profile of resistance mutations in vitro.
Cancer research 2009;69(7):3032-41.
2009: Thomas Decker; Michael Sandherr; Katharina Goetze; Madlene Oelsner; Ingo Ringshausen; Christian Peschel
A pilot trial of the mTOR (mammalian target of rapamycin) inhibitor RAD001 in patients with advanced B-CLL.
Annals of hematology 2009;88(3):221-7.
2009: Catharina Müller-Thomas; Tibor Schuster; Christian Peschel; Katharina S Götze
A limited number of 5-azacitidine cycles can be effective treatment in MDS.
Annals of hematology 2009;88(3):213-9.
2009: Kathrin Abbrederis; Sylvie Lorenzen; Nadine Rothling; Angela Ihbe-Heffinger; Tibor Schuster; Christian Peschel; Florian Lordick
Chemotherapy-induced nausea and vomiting in the treatment of gastrointestinal tumors and secondary prophylaxis with aprepitant.
Onkologie 2009;32(1-2):30-4.
2009: Rama Krishna Kancha; Nikolas von Bubnoff; Christian Peschel; Justus Duyster
Functional analysis of epidermal growth factor receptor (EGFR) mutations and potential implications for EGFR targeted therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(2):460-7.
2009: Ks Götze; C Müller-Thomas; Christian Peschel
The role of azacitidine in the management of myelodysplastic syndromes (MDS).
Cancer management and research 2009;1():119-30.
2008: Rama Krishna Kancha; Nikolas von Bubnoff; Cornelius Miething; Christian Peschel; Katharina S Götze; Justus Duyster
Imatinib and leptomycin B are effective in overcoming imatinib-resistance due to Bcr-Abl amplification and clonal evolution but not due to Bcr-Abl kinase domain mutation.
Haematologica 2008;93(11):1718-22.
2008: Nicolas Graf; Ken Herrmann; Jürgen den Hollander; Falko Fend; Tibor Schuster; Hans-Jürgen Wester; Reingard Senekowitsch-Schmidtke; Christian Meyer zum Büschenfelde; Christian Peschel; Markus Schwaiger; Tobias Dechow; Andreas K Buck
Imaging proliferation to monitor early response of lymphoma to cytotoxic treatment.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2008;10(6):349-55.
2008: Sylvie Lorenzen; Björn L.D.M. Brücher; Frank B Zimmermann; Hans Geinitz; J Riera; T Schuster; N Roethling; Heinz Höfler; Katja Ott; Christian Peschel; Jörg Rüdiger Siewert; Michael Molls; Florian Lordick
Neoadjuvant continuous infusion of weekly 5-fluorouracil and escalating doses of oxaliplatin plus concurrent radiation in locally advanced oesophageal squamous cell carcinoma: results of a phase I/II trial.
British journal of cancer 2008;99(7):1020-6.
2008: Olaf Gross; Christina Grupp; Christian Steinberg; Stephanie Zimmermann; Dominikus Strasser; Nicole Hannesschläger; Wolfgang Reindl; Helena Jonsson; Hairong Huo; Dan R Littman; Christian Peschel; Wayne M Yokoyama; Anne Krug; Jürgen Ruland
Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-kappaB and MAPK activation to selectively control cytokine production.
Blood 2008;112(6):2421-8.
2008: Nikolas Kaltz; Alessia Funari; Sandra Hippauf; Bruno Delorme; Danièle Noël; Mara Riminucci; Volker R Jacobs; Thomas Häupl; Christian Jorgensen; Pierre Charbord; Christian Peschel; Paolo Bianco; Robert Oostendorp
In vivo osteoprogenitor potency of human stromal cells from different tissues does not correlate with expression of POU5F1 or its pseudogenes.
Stem cells (Dayton, Ohio) 2008;26(9):2419-24.
2008: Helge Menzel; Andrea Müller; Christoph von Schilling; Thomas Licht; Christian Peschel; Ulrich Keller
Ifosfamide, epirubicin and etoposide rituximab in refractory or relapsed B-cell lymphoma: analysis of remission induction and stem cell mobilization.
Leukemia & lymphoma 2008;49(7):1337-44.
2008: Christian Meyer zum Büschenfelde; Yvonne Feuerstacke; Katharina S Götze; Katrin Scholze; Christian Peschel
GM1 expression of non-Hodgkin's lymphoma determines susceptibility to rituximab treatment.
Cancer research 2008;68(13):5414-22.
2008: Heinke Conrad; Kerstin Gebhard; Holger Krönig; Julia Neudorfer; Dirk H Busch; Christian Peschel; Helga Bernhard
CTLs directed against HER2 specifically cross-react with HER3 and HER4.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(12):8135-45.
2008: Ambros J Beer; Konstantin Holzapfel; Juliana Neudorfer; Guido Piontek; Marcus Settles; Holger Krönig; Christian Peschel; Jürgen Schlegel; Ernst J Rummeny; Helga Bernhard
Visualization of antigen-specific human cytotoxic T lymphocytes labeled with superparamagnetic iron-oxide particles.
European radiology 2008;18(6):1087-95.
2008: Andreas K Buck; Ken Herrmann; Christian Meyer Zum Büschenfelde; Malik E Juweid; Mark Bischoff; Gerhard Glatting; Gregor Weirich; Peter Möller; Hans-Jürgen Wester; Klemens Scheidhauer; Tobias Dechow; Christian Peschel; Markus Schwaiger; Sven N Reske
Imaging bone and soft tissue tumors with the proliferation marker [18F]fluorodeoxythymidine.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(10):2970-7.
2008: K Abbrederis; Sylvie Lorenzen; L Fischer von Weikersthal; Ursula Vehling-Kaiser; T Schuster; N Rothling; Christian Peschel; Florian Lordick
Weekly docetaxel monotherapy for advanced gastric or esophagogastric junction cancer. Results of a phase II study in elderly patients or patients with impaired performance status.
Critical reviews in oncology/hematology 2008;66(1):84-90.
2008: Helga Bernhard; Julia Neudorfer; Kerstin Gebhard; Heinke Conrad; Christine Hermann; Jörg Nährig; Falko Fend; Wolfgang Weber; Dirk H Busch; Christian Peschel
Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer.
Cancer immunology, immunotherapy : CII 2008;57(2):271-80.
2008: Ambros J Beer; Sylvie Lorenzen; Stephan Metz; Ken Herrmann; Petra Watzlowik; Hans-Jürgen Wester; Christian Peschel; Florian Lordick; Markus Schwaiger
Comparison of integrin alphaVbeta3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: a PET study using 18F-galacto-RGD and 18F-FDG.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(1):22-9.
2007: Joerg R Siewert; Florian Lordick; Katja Ott; Hubert J Stein; Wolfgang A Weber; Karen Becker; Christian Peschel; Ulrich Fink; Markus Schwaiger
Induction chemotherapy in Barrett cancer: influence on surgical risk and outcome.
Annals of surgery 2007;246(4):624-8; discussion 628-31.
2007: Rama Krishna Kancha; Rebekka Grundler; Christian Peschel; Justus Duyster
Sensitivity toward sorafenib and sunitinib varies between different activating and drug-resistant FLT3-ITD mutations.
Experimental hematology 2007;35(10):1522-6.
2007: Sylvie Lorenzen; Marcus Hentrich; C Haberl; Volker Heinemann; T Schuster; T Seroneit; N Roethling; Christian Peschel; Florian Lordick
Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(10):1673-9.
2007: Florian Scheich; Justus Duyster; Christian Peschel; Helga Bernhard
The immunogenicity of Bcr-Abl expressing dendritic cells is dependent on the Bcr-Abl kinase activity and dominated by Bcr-Abl regulated antigens.
Blood 2007;110(7):2556-60.
2007: Florian Lordick; Katja Ott; Bernd J Krause; Wolfgang A Weber; Karen Becker; Hubert J Stein; Sylvie Lorenzen; Tibor Schuster; Hinrich A Wieder; Ken Herrmann; Rainer Bredenkamp; Heinz Höfler; Ulrich Fink; Christian Peschel; Markus Schwaiger; Jörg R Siewert
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial.
The lancet oncology 2007;8(9):797-805.
2007: Uta Ferch; Christian Meyer zum Büschenfelde; Andreas Gewies; Elmar Wegener; Sandra Rauser; Christian Peschel; Daniel Krappmann; Jürgen Ruland
MALT1 directs B cell receptor-induced canonical nuclear factor-kappaB signaling selectively to the c-Rel subunit.
Nature immunology 2007;8(9):984-91.
2007: H Menzel; Nikolas von Bubnoff; Andreas Hochhaus; C Haferlach; Christian Peschel; Justus Duyster
Successful allogeneic stem cell transplantation in second chronic-phase CML induced by the tyrosine kinase inhibitor nilotinib (AMN107) after blast crisis under imatinib.
Bone marrow transplantation 2007;40(1):83-4.
2007: Ken Herrmann; Hinrich A Wieder; Andreas K Buck; Marion Schöffel; Bernd J Krause; Falko Fend; Tibor Schuster; Christian Meyer zum Büschenfelde; Hans-Jürgen Wester; Justus Duyster; Christian Peschel; Markus Schwaiger; Tobias Dechow
Early response assessment using 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography in high-grade non-Hodgkin's lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(12):3552-8.
2007: Florian Bassermann; Christine von Klitzing; Anna Lena Illert; Silvia Münch; Stephan W Morris; Michele Pagano; Christian Peschel; Justus Duyster
Multisite phosphorylation of nuclear interaction partner of ALK (NIPA) at G2/M involves cyclin B1/Cdk1.
The Journal of biological chemistry 2007;282(22):15965-72.
2007: Julia Neudorfer; Burkhard Schmidt; Katharina M Huster; Florian Anderl; Matthias Schiemann; Gerd Holzapfel; Thomas Schmidt; Lothar Germeroth; Hermann Wagner; Christian Peschel; Dirk H Busch; Helga Bernhard
Reversible HLA multimers (Streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor- and virus-derived antigens.
Journal of immunological methods 2007;320(1-2):119-31.
2007: Cornelius Miething; Rebekka Grundler; Claudia Mugler; Simone Brero; Josef Hoepfl; Jochen Geigl; Michael R Speicher; Oliver G Ottmann; Christian Peschel; Justus Duyster
Retroviral insertional mutagenesis identifies RUNX genes involved in chronic myeloid leukemia disease persistence under imatinib treatment.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(11):4594-9.
2007: Philipp J Jost; Stephanie Weiss; Uta Ferch; Olaf Gross; Tak W Mak; Christian Peschel; Jürgen Ruland
Bcl10/Malt1 signaling is essential for TCR-induced NF-kappaB activation in thymocytes but dispensable for positive or negative selection.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(2):953-60.
2007: Stefanie Klemm; Stephanie Zimmermann; Christian Peschel; Tak W Mak; Jürgen Ruland
Bcl10 and Malt1 control lysophosphatidic acid-induced NF-kappaB activation and cytokine production.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(1):134-8.
2007: Sylvie Lorenzen; Ken Herrmann; Wolfgang A Weber; Hinrich A Wieder; M Hennig; Katja Ott; Rainer Bredenkamp; Christian Peschel; Markus Schwaiger; Florian Lordick
Visualisation of metastatic oesophageal and gastric cancer and prediction of clinical response to palliative chemotherapy using 18FDG PET.
Nuklearmedizin. Nuclear medicine 2007;46(6):263-70.
2006: Ingo Ringshausen; Christian Peschel; Thomas Decker
Cell cycle inhibition in malignant lymphoma: disease control by attacking the cellular proliferation machinery.
Current drug targets 2006;7(10):1349-59.
2006: Philipp J Jost; Christian Peschel; Jürgen Ruland
The Bcl10/Malt1 signaling pathway as a drug target in lymphoma.
Current drug targets 2006;7(10):1335-40.
2006: Cornelius Miething; Christian Peschel; Justus Duyster
Targeting the oncogenic tyrosine kinase NPM-ALK in lymphoma: the role of murine models in defining pathogenesis and treatment options.
Current drug targets 2006;7(10):1329-34.
2006: Kathrin Wanner; Susanne Hipp; Madlene Oelsner; Ingo Ringshausen; Christian Bogner; Christian Peschel; Thomas Decker
Mammalian target of rapamycin inhibition induces cell cycle arrest in diffuse large B cell lymphoma (DLBCL) cells and sensitises DLBCL cells to rituximab.
British journal of haematology 2006;134(5):475-84.
2006: Nikolas von Bubnoff; Paul W Manley; Jürgen Mestan; Jana Sanger; Christian Peschel; Justus Duyster
Bcr-Abl resistance screening predicts a limited spectrum of point mutations to be associated with clinical resistance to the Abl kinase inhibitor nilotinib (AMN107).
Blood 2006;108(4):1328-33.
2006: Olaf Gross; Andreas Gewies; Katrin Finger; Martin Schäfer; Tim D. Sparwasser; Christian Peschel; Irmgard Förster; Jürgen Ruland
Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity.
Nature 2006;442(7103):651-6.
2006: Wolfgang Kastenmuller; Ingo Drexler; Holger Ludwig; Volker Erfle; Christian Peschel; Helga Bernhard; Gerd Sutter
Infection of human dendritic cells with recombinant vaccinia virus MVA reveals general persistence of viral early transcription but distinct maturation-dependent cytopathogenicity.
Virology 2006;350(2):276-88.
2006: Kathrin Abbrederis; Florian Bassermann; Christoph Schuhmacher; Verena Voelter; Raymonde Busch; Nadine Roethling; Andreas Sendler; Joerg R Siewert; Christian Peschel; Florian Lordick
Erythropoietin-alfa during neoadjuvant chemotherapy for locally advanced esophagogastric adenocarcinoma.
The Annals of thoracic surgery 2006;82(1):293-7.
2006: Christian Bogner; Michael Sandherr; Michael Perker; Katrin Weick; Ingo Ringshausen; Christian Peschel; Thomas Decker
Cyclin E but not bcl-2, bax or mcl-1 is differentially expressed in ZAP 70-positive and ZAP 70-negative B-CLL cells.
Annals of hematology 2006;85(7):458-62.
2006: Nikolas von Bubnoff; Sivahari Prasad Gorantla; Silvia Thöne; Christian Peschel; Justus Duyster
The FIP1L1-PDGFRA T674I mutation can be inhibited by the tyrosine kinase inhibitor AMN107 (nilotinib).
Blood 2006;107(12):4970-1; author reply 4972.
2006: Cornelius Miething; S Feihl; Claudia Mugler; Rebekka Grundler; Nikolas von Bubnoff; F Lordick; Christian Peschel; Justus Duyster
The Bcr-Abl mutations T315I and Y253H do not confer a growth advantage in the absence of imatinib.
Leukemia 2006;20(4):650-7.
2006: Ingo Ringshausen; Madlene Oelsner; Katrin Weick; Christian Bogner; Christian Peschel; Thomas Decker
Mechanisms of apoptosis-induction by rottlerin: therapeutic implications for B-CLL.
Leukemia 2006;20(3):514-20.
2006: Stefanie Klemm; Jan Gutermuth; Lothar Hültner; Tim D. Sparwasser; Heidrun Behrendt; Christian Peschel; Tak W Mak; Thilo Jakob; Jürgen Ruland
The Bcl10-Malt1 complex segregates Fc epsilon RI-mediated nuclear factor kappa B activation and cytokine production from mast cell degranulation.
The Journal of experimental medicine 2006;203(2):337-47.
2006: Christian Bogner; Christian Peschel; Thomas Decker
Targeting the proteasome in mantle cell lymphoma: a promising therapeutic approach.
Leukemia & lymphoma 2006;47(2):195-205.
2005: Florian Bassermann; Christian Peschel; Justus Duyster
Mitotic entry: a matter of oscillating destruction.
Cell cycle (Georgetown, Tex.) 2005;4(11):1515-7.
2005: Susanne Hipp; Ingo Ringshausen; Madlene Oelsner; Christian Bogner; Christian Peschel; Thomas Decker
Inhibition of the mammalian target of rapamycin and the induction of cell cycle arrest in mantle cell lymphoma cells.
Haematologica 2005;90(10):1433-4.
2005: J Dengler; Nikolas von Bubnoff; T Decker; Christian Peschel; Justus Duyster
Combination of imatinib with rapamycin or RAD001 acts synergistically only in Bcr-Abl-positive cells with moderate resistance to imatinib.
Leukemia 2005;19(10):1835-8.
2005: Nikolas von Bubnoff; S H P Gorantla; Rama Krishna Kancha; F Lordick; Christian Peschel; Justus Duyster
The systemic mastocytosis-specific activating cKit mutation D816V can be inhibited by the tyrosine kinase inhibitor AMN107.
Leukemia 2005;19(9):1670-1.
2005: Florian Lordick; Sylvie Lorenzen; Jens Stollfuss; Ursula Vehling-Kaiser; Frank Kullmann; Marcus Hentrich; R Zumschlinge; H Dietzfelbinger; J Thoedtmann; M Hennig; T Seroneit; Rainer Bredenkamp; J Duyster; Christian Peschel
Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer.
British journal of cancer 2005;93(2):190-4.
2005: Florian Bassermann; Christine von Klitzing; Silvia Münch; RENYUAN BAI; Hiroyuki Kawaguchi; Stephan W Morris; Christian Peschel; Justus Duyster
NIPA defines an SCF-type mammalian E3 ligase that regulates mitotic entry.
Cell 2005;122(1):45-57.
2005: Sylvie Lorenzen; J Duyster; Christian Lersch; Stefan von Delius; M Hennig; Rainer Bredenkamp; Christian Peschel; Florian Lordick
Capecitabine plus docetaxel every 3 weeks in first- and second-line metastatic oesophageal cancer: final results of a phase II trial.
British journal of cancer 2005;92(12):2129-33.
2005: Rebekka Grundler; Cornelius Miething; Christian Thiede; Christian Peschel; Justus Duyster
FLT3-ITD and tyrosine kinase domain mutants induce 2 distinct phenotypes in a murine bone marrow transplantation model.
Blood 2005;105(12):4792-9.
2005: Susanne Urschel; Florian Bassermann; RENYUAN BAI; Silvia Münch; Christian Peschel; Justus Duyster
Phosphorylation of grb10 regulates its interaction with 14-3-3.
The Journal of biological chemistry 2005;280(17):16987-93.
2005: Florian Lordick; Angela Ihbe-Heffinger; Christian Peschel
[Antiemetic prophylaxis in the chemotherapy of gastrointestinal tumours].
Zeitschrift für Gastroenterologie 2005;43(4):391-8.
2005: Nikolas von Bubnoff; Simone Barwisch; Michael R Speicher; Christian Peschel; Justus Duyster
A cell-based screening strategy that predicts mutations in oncogenic tyrosine kinases: implications for clinical resistance in targeted cancer treatment.
Cell cycle (Georgetown, Tex.) 2005;4(3):400-6.
2005: Nikolas von Bubnoff; Darren R Veach; Heiko van der Kuip; Walter Aulitzky; Jana Sänger; Petra Seipel; William G Bornmann; Christian Peschel; Bayard Clarkson; Justus Duyster
A cell-based screen for resistance of Bcr-Abl-positive leukemia identifies the mutation pattern for PD166326, an alternative Abl kinase inhibitor.
Blood 2005;105(4):1652-9.
2005: Nikolas von Bubnoff; Michael Sandherr; Günter Schlimok; R Andreesen; Christian Peschel; Justus Duyster
Myeloid blast crisis evolving during imatinib treatment of an FIP1L1-PDGFR alpha-positive chronic myeloproliferative disease with prominent eosinophilia.
Leukemia 2005;19(2):286-7.
2005: Ingo Ringshausen; Christian Peschel; Thomas Decker
Mammalian target of rapamycin (mTOR) inhibition in chronic lymphocytic B-cell leukemia: a new therapeutic option.
Leukemia & lymphoma 2005;46(1):11-9.
2005: Helga Bernhard; Burkhard Schmidt; Dirk H Busch; Christian Peschel
Isolation and expansion of tumor-reactive cytotoxic T-cell clones for adoptive immunotherapy.
Methods in molecular medicine 2005;109():175-84.
2004: Ingo Ringshausen; T Dechow; Folker Schneller; Katrin Weick; Madlene Oelsner; Christian Peschel; Thomas Decker
Constitutive activation of the MAPkinase p38 is critical for MMP-9 production and survival of B-CLL cells on bone marrow stromal cells.
Leukemia 2004;18(12):1964-70.
2004: Nikolas von Bubnoff; Christian Peschel; Justus Duyster
[An alternative Abl-kinase inhibitor overcomes imatinib resistance mutations of Bcr-Abl oncogenes].
Deutsche medizinische Wochenschrift (1946) 2004;129(40):2100-3.
2004: Verena Voelter; Christoph Schuhmacher; Raymonde Busch; Christian Peschel; Jörg Rüdiger Siewert; Florian Lordick
Incidence of anemia in patients receiving neoadjuvant chemotherapy for locally advanced esophagogastric cancer.
The Annals of thoracic surgery 2004;78(3):1037-41.
2004: Thomas Kindler; Frank Breitenbuecher; Andreas Marx; Joachim Beck; Georg Hess; Birgit Weinkauf; Justus Duyster; Christian Peschel; Charles James Kirkpatrick; Matthias Theobald; Harald Gschaidmeier; Christoph Huber; Thomas Fischer
Efficacy and safety of imatinib in adult patients with c-kit-positive acute myeloid leukemia.
Blood 2004;103(10):3644-54.
2004: Thomas Decker; Susanne Hipp; Ines Hahntow; Folker Schneller; Christian Peschel
Expression of cyclin E in resting and activated B-chronic lymphocytic leukaemia cells: cyclin E/cdk2 as a potential therapeutic target.
British journal of haematology 2004;125(2):141-8.
2004: Ines Hahntow; Folker Schneller; Madlene Oelsner; Katrin Weick; Ingo Ringshausen; Falko Fend; Christian Peschel; Thomas Decker
Cyclin-dependent kinase inhibitor Roscovitine induces apoptosis in chronic lymphocytic leukemia cells.
Leukemia 2004;18(4):747-55.
2004: Thomas Decker; Madlene Oelsner; Robert J Kreitman; Giuliana Salvatore; Qing-Cheng Wang; Ira Pastan; Christian Peschel; Thomas Licht
Induction of caspase-dependent programmed cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins.
Blood 2004;103(7):2718-26.
2004: Angela Ihbe-Heffinger; Birgit Ehlken; R Bernard; Karin Berger; Christian Peschel; H-G Eichler; Robert Deuson; J Thödtmann; Florian Lordick
The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(3):526-36.
2004: Kristina Fleischer; Burkhard Schmidt; Wolfgang Kastenmüller; Dirk H Busch; Ingo Drexler; Gerd Sutter; Michael Heike; Christian Peschel; Helga Bernhard
Melanoma-reactive class I-restricted cytotoxic T cell clones are stimulated by dendritic cells loaded with synthetic peptides, but fail to respond to dendritic cells pulsed with melanoma-derived heat shock proteins in vitro.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(1):162-9.
2003: Nikolas von Bubnoff; Darren R Veach; W Todd Miller; Wanqing Li; Jana Sänger; Christian Peschel; William G Bornmann; Bayard Clarkson; Justus Duyster
Inhibition of wild-type and mutant Bcr-Abl by pyrido-pyrimidine-type small molecule kinase inhibitors.
Cancer research 2003;63(19):6395-404.
2003: Cornelius Miething; Claudia Mugler; Rebekka Grundler; Josef Hoepfl; RENYUAN BAI; Christian Peschel; Justus Duyster
Phosphorylation of tyrosine 393 in the kinase domain of Bcr-Abl influences the sensitivity towards imatinib in vivo.
Leukemia 2003;17(9):1695-9.
2003: Florian Lordick; Christoph von Schilling; H Bernhard; M Hennig; Rainer Bredenkamp; Christian Peschel
Phase II trial of irinotecan plus docetaxel in cisplatin-pretreated relapsed or refractory oesophageal cancer.
British journal of cancer 2003;89(4):630-3.
2003: Tao Ouyang; RENYUAN BAI; Florian Bassermann; Christine von Klitzing; Silvia Klumpen; Cornelius Miething; Stephan W Morris; Christian Peschel; Justus Duyster
Identification and characterization of a nuclear interacting partner of anaplastic lymphoma kinase (NIPA).
The Journal of biological chemistry 2003;278(32):30028-36.
2003: Cornelius Miething; Rebekka Grundler; Falco Fend; Josef Hoepfl; Claudia Mugler; Christoph von Schilling; Stephan W Morris; Christian Peschel; Justus Duyster
The oncogenic fusion protein nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) induces two distinct malignant phenotypes in a murine retroviral transplantation model.
Oncogene 2003;22(30):4642-7.
2003: Rebekka Grundler; Christian Thiede; Cornelius Miething; Christine Steudel; Christian Peschel; Justus Duyster
Sensitivity toward tyrosine kinase inhibitors varies between different activating mutations of the FLT3 receptor.
Blood 2003;102(2):646-51.
2003: Christian Bogner; Ingo Ringshausen; Folker Schneller; Falko Fend; Leticia Quintanilla-Martinez; Georg Häcker; Katharina Goetze; Robert Oostendorp; Christian Peschel; Thomas Decker
Inhibition of the proteasome induces cell cycle arrest and apoptosis in mantle cell lymphoma cells.
British journal of haematology 2003;122(2):260-8.
2003: Nikolas von Bubnoff; Christian Peschel; Justus Duyster
Resistance of Philadelphia-chromosome positive leukemia towards the kinase inhibitor imatinib (STI571, Glivec): a targeted oncoprotein strikes back.
Leukemia 2003;17(5):829-38.
2003: Florian Lordick; Marcus Hentrich; Thomas Decker; Michael Hennig; Hans Pohlmann; Reiner Hartenstein; Christian Peschel
Ultrasound screening for internal jugular vein thrombosis aids the detection of central venous catheter-related infections in patients with haemato-oncological diseases: a prospective observational study.
British journal of haematology 2003;120(6):1073-8.
2003: Christian Bogner; Folker Schneller; Susanne Hipp; Ingo Ringshausen; Christian Peschel; Thomas Decker
Cycling B-CLL cells are highly susceptible to inhibition of the proteasome: involvement of p27, early D-type cyclins, Bax, and caspase-dependent and -independent pathways.
Experimental hematology 2003;31(3):218-25.
2003: Harald Gündel; Florian Lordick; Tobias Brandl; Florian Würschmidt; Jutta Schüssler; Birgit Leps; Andreas Sendler; Erdal Mert; Doris Pouget-Schors; Christoph von Schilling; Christian Peschel; Almuth Sellschopp
[Interdisciplinary psychoeducational intervention by oncologists proved helpful for cancer patients].
Zeitschrift für Psychosomatische Medizin und Psychotherapie 2003;49(3):246-61.
2003: Thomas Decker; Susanne Hipp; Ingo Ringshausen; Christian Bogner; Madlene Oelsner; Folker Schneller; Christian Peschel
Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin.
Blood 2003;101(1):278-85.
2002: Ingo Ringshausen; Folker Schneller; Christian Bogner; Susanne Hipp; Justus Duyster; Christian Peschel; Thomas Decker
Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta.
Blood 2002;100(10):3741-8.
2002: Klemens Scheidhauer; Ingo Wolf; Hans-Joachim Baumgartl; Christoph von Schilling; Burkhard Schmidt; Günther Reidel; Christian Peschel; Markus Schwaiger
Biodistribution and kinetics of (131)I-labelled anti-CD20 MAB IDEC-C2B8 (rituximab) in relapsed non-Hodgkin's lymphoma.
European journal of nuclear medicine and molecular imaging 2002;29(10):1276-82.
2002: Josef Hoepfl; Cornelius Miething; Rebekka Grundler; K S Götze; Christian Peschel; Justus Duyster
Effects of imatinib on bone marrow engraftment in syngeneic mice.
Leukemia 2002;16(9):1584-8.
2002: Florian Lordick; Harald Gündel; Christoph von Schilling; Florian Würschmidt; Birgit Leps; Andreas Sendler; Jutta Schüssler; Tobias Brandl; Christian Peschel; Almuth Sellschopp
[Structured patient education in oncology. A prospective study for implementing and effectiveness of interdisciplinary psycho-educational group intervention at a German university clinic].
Medizinische Klinik (Munich, Germany : 1983) 2002;97(8):449-54.
2002: Thomas Jahn; Petra Seipel; Sunita Coutinho; Susanne Urschel; Kathleen Schwarz; Cornelius Miething; Hubert Serve; Christian Peschel; Justus Duyster
Analysing c-kit internalization using a functional c-kit-EGFP chimera containing the fluorochrome within the extracellular domain.
Oncogene 2002;21(29):4508-20.
2002: Thomas Licht; Christian Peschel
Restoration of transgene expression in hematopoietic cells with drug-selectable marker genes.
Current gene therapy 2002;2(2):227-34.
2002: Christian Meyer zum Büschenfelde; Christine Hermann; Burkhard Schmidt; Christian Peschel; Helga Bernhard
Antihuman epidermal growth factor receptor 2 (HER2) monoclonal antibody trastuzumab enhances cytolytic activity of class I-restricted HER2-specific T lymphocytes against HER2-overexpressing tumor cells.
Cancer research 2002;62(8):2244-7.
2002: Florian Bassermann; Thomas Jahn; Cornelius Miething; Petra Seipel; RENYUAN BAI; Sunita Coutinho; Victor L J Tybulewicz; Christian Peschel; Justus Duyster
Association of Bcr-Abl with the proto-oncogene Vav is implicated in activation of the Rac-1 pathway.
The Journal of biological chemistry 2002;277(14):12437-45.
2002: Marit D Harzenetter; Ulrich Keller; Sandra Beer; Claudia Riedl; Christian Peschel; Bernhard Holzmann
Regulation and function of the CGRP receptor complex in human granulopoiesis.
Experimental hematology 2002;30(4):306-12.
2002: Thomas Decker; Folker Schneller; Susanne Hipp; Cornelius Miething; Thomas Jahn; Justus Duyster; Christian Peschel
Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
Leukemia 2002;16(3):327-34.
2002: RENYUAN BAI; Christina Koester; Tao Ouyang; Stephan Hahn; Matthias Hammerschmidt; Christian Peschel; Justus Duyster
SMIF, a Smad4-interacting protein that functions as a co-activator in TGFbeta signalling.
Nature cell biology 2002;4(3):181-90.
2002: Thomas Decker; Susanne Hipp; Robert J Kreitman; Ira Pastan; Christian Peschel; Thomas Licht
Sensitization of B-cell chronic lymphocytic leukemia cells to recombinant immunotoxin by immunostimulatory phosphorothioate oligodeoxynucleotides.
Blood 2002;99(4):1320-6.
2002: Nikolas von Bubnoff; Folker Schneller; Christian Peschel; Justus Duyster
BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study.
Lancet 2002;359(9305):487-91.
2002: Thomas Jahn; Petra Seipel; Susanne Urschel; Christian Peschel; Justus Duyster
Role for the adaptor protein Grb10 in the activation of Akt.
Molecular and cellular biology 2002;22(4):979-91.
2001: Thomas Jahn; Petra Seipel; Sunita Coutinho; Cornelius Miething; Christian Peschel; Justus Duyster
Grb4/Nckbeta acts as a nuclear repressor of v-Abl-induced transcription from c-jun/c-fos promoter elements.
The Journal of biological chemistry 2001;276(46):43419-27.
2001: Udo Hartwig; U Keller; Christoph Huber; Christian Peschel
Regulation of hematopoietic growth factor production by genetically modified human bone marrow stromal cells expressing interleukin-1beta antisense RNA.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2001;21(10):851-60.
2001: Christian Meyer zum Büschenfelde; Jochen Metzger; Christine Hermann; N Nicklisch; Christian Peschel; Helga Bernhard
The generation of both T killer and Th cell clones specific for the tumor-associated antigen HER2 using retrovirally transduced dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(3):1712-9.
2001: Thomas Decker; Christian Peschel
Effect of immunostimulatory CpG-oligonucleotides in chronic lymphocytic leukemia B cells.
Leukemia & lymphoma 2001;42(3):301-7.
2001: Michael Sandherr; C von Schilling; T Link; K Stock; Nikolas von Bubnoff; Christian Peschel; N Avril
Pitfalls in imaging Hodgkin's disease with computed tomography and positron emission tomography using fluorine-18-fluorodeoxyglucose.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(5):719-22.
2000: RENYUAN BAI; Tao Ouyang; Cornelius Miething; Stephan W Morris; Christian Peschel; Justus Duyster
Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway.
Blood 2000;96(13):4319-27.
2000: C Meyer zum Büschenfelde; N Nicklisch; S Rose-John; Christian Peschel; Helga Bernhard
Generation of tumor-reactive CTL against the tumor-associated antigen HER2 using retrovirally transduced dendritic cells derived from CD34+ hemopoietic progenitor cells.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(7):4133-40.
2000: Sunita Coutinho; Thomas Jahn; Marc Lewitzky; Stephan M Feller; P Hutzler; Christian Peschel; Justus Duyster
Characterization of Ggrb4, an adapter protein interacting with Bcr-Abl.
Blood 2000;96(2):618-24.
2000: S H Hoischen; Petra Vollmer; Pia März; Suat Ozbek; K S Götze; Christian Peschel; Thomas Jostock; T Geib; Jürgen Müllberg; S Mechtersheimer; Martina Fischer; Joachim Grötzinger; Peter R Galle; Stefan Rose-John
Human herpes virus 8 interleukin-6 homologue triggers gp130 on neuronal and hematopoietic cells.
European journal of biochemistry / FEBS 2000;267(12):3604-12.
2000: Thomas Decker; Folker Schneller; M Kronschnabl; T Dechow; Grayson Lipford; H Wagner; Christian Peschel
Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: costimulation with IL-2 results in a highly immunogenic phenotype.
Experimental hematology 2000;28(5):558-68.
2000: Nikolas von Bubnoff; Michael Sandherr; Folker Schneller; Christian Peschel
Thrombotic thrombocytopenic purpura in metastatic carcinoma of the breast.
American journal of clinical oncology 2000;23(1):74-7.
2000: Thomas Decker; Folker Schneller; Tim D. Sparwasser; T Tretter; Grayson Lipford; H Wagner; Christian Peschel
Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells.
Blood 2000;95(3):999-1006.
1999: G Göllner; G Bug; B Rupilius; Christian Peschel; Christoph Huber; Hans Günter Derigs
Regulatory elements of the leukaemia inhibitory factor (LIF) promoter in murine bone marrow stromal cells.
Cytokine 1999;11(9):656-63.
1999: U Brass; T Tretter; Folker Schneller; Martin Schuler; Christoph Huber; Christian Peschel
IFN-alpha stimulates proliferation and cytokine secretion of CD40-stimulated B cell chronic lymphocytic leukemia cells in vitro.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1999;19(4):335-43.
1999: Martin Schuler; T Tretter; Folker Schneller; Christoph Huber; Christian Peschel
Autocrine transforming growth factor-beta from chronic lymphocytic leukemia-B cells interferes with proliferative T cell signals.
Immunobiology 1999;200(1):128-39.
1998: RENYUAN BAI; P Dieter; Christian Peschel; Stephan W Morris; Justus Duyster
Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity.
Molecular and cellular biology 1998;18(12):6951-61.
1998: Folker Schneller; Martin Schuler; K Schumacher; J Thaler; Christian Peschel; Christoph Huber; Walter Aulitzky
Idarubicin and intermediate-dose cytarabine for myeloid blast crisis of chronic myelogenous leukemia--results of a phase-II trial.
Annals of hematology 1998;77(5):225-9.
1998: T Tretter; Martin Schuler; Folker Schneller; U Brass; M Esswein; MJ Aman; Christoph Huber; Christian Peschel
Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.
Cellular immunology 1998;189(1):41-50.
1998: Martin Schuler; U Bruntsch; Ernst Späth-Schwalbe; H Schrezenmeier; Christian Peschel; Lothar Färber; KJ Burger; Joachim Leissner; C Huber; Walter Aulitzky
Lack of efficacy of recombinant human interleukin-6 in patients with advanced renal cell cancer: results of a phase II study.
European journal of cancer (Oxford, England : 1990) 1998;34(5):754-6.
1998: T Tretter; MJ Aman; G Bug; Christoph Huber; Christian Peschel
Hematopoietic growth factors are differentially regulated in monocytes and CD4+ T lymphocytes: influence of IFN-alpha and interleukin-4.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1998;18(2):95-102.
1998: T Jonuleit; Christian Peschel; R Schwab; Heiko van der Kuip; E Buchdunger; T Fischer; C Huber; Walter Aulitzky
Bcr-Abl kinase promotes cell cycle entry of primary myeloid CML cells in the absence of growth factors.
British journal of haematology 1998;100(2):295-303.
1998: G Bug; MJ Aman; T Tretter; Christoph Huber; Christian Peschel
Induction of macrophage-inflammatory protein 1alpha (MIP-1alpha) by interferon-alpha.
Experimental hematology 1998;26(2):117-23.
1998: M Heuser; H van der Kuip; B Falini; Christian Peschel; Christoph Huber; T Fischer
Induction of the pro-myelocytic leukaemia gene by type I and type II interferons.
Mediators of inflammation 1998;7(5):319-25.
1998: G Bug; J Aman; Christoph Huber; Christian Peschel; Hans Günter Derigs
cAMP analogues downregulate the expression of granulocyte macrophage colony-stimulating factor (GM-CSF) in human bone marrow stromal cells in vitro.
Mediators of inflammation 1998;7(3):195-9.
1997: Karin Kolbe; Christian Peschel; B Rupilius; D Després; KJ Burger; I Sklenar; Lothar Färber; Christoph Huber; Hans Günter Derigs
Peripheral blood stem cell (PBSC) mobilization with chemotherapy followed by sequential IL-3 and G-CSF administration in extensively pretreated patients.
Bone marrow transplantation 1997;20(12):1027-32.
1997: M Peters; Peter Schirmacher; J Goldschmitt; M Odenthal; Christian Peschel; Elena Fattori; Gennaro Ciliberto; Hans P Dienes; Karl-Hermann Meyer zum Büschenfelde; Stefan Rose-John
Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sIL-6R double transgenic mice.
The Journal of experimental medicine 1997;185(4):755-66.
1997: Martina Fischer; J Goldschmitt; Christian Peschel; J P Brakenhoff; Karl-Josef Kallen; Axel Wollmer; Joachim Grötzinger; Stefan Rose-John
I. A bioactive designer cytokine for human hematopoietic progenitor cell expansion.
Nature biotechnology 1997;15(2):142-5.
1996: T Albrecht; R Schwab; M Henkes; Christian Peschel; Christoph Huber; Walter Aulitzky
Primary proliferating immature myeloid cells from CML patients are not resistant to induction of apoptosis by DNA damage and growth factor withdrawal.
British journal of haematology 1996;95(3):501-7.
1996: M J Aman; K Stockdreher; A Thews; K Kienast; Walter Aulitzky; Lothar Färber; Ulrike Haus; B Koci; Christoph Huber; Christian Peschel
Regulation of immunomodulatory functions by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in vivo.
Annals of hematology 1996;73(5):231-8.
1996: Martin Schuler; Christian Peschel; Folker Schneller; Jan Fichtner; Lothar Färber; Christoph Huber; Walter Aulitzky
Immunomodulatory and hematopoietic effects of recombinant human interleukin-6 in patients with advanced renal cell cancer.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1996;16(11):903-10.
1996: M J Aman; G Bug; Walter Aulitzky; Christoph Huber; Christian Peschel
Inhibition of interleukin-11 by interferon-alpha in human bone marrow stromal cells.
Experimental hematology 1996;24(8):863-7.
1996: M J Aman; T Tretter; I Eisenbeis; G Bug; T Decker; Walter Aulitzky; Herbert Tilg; Christoph Huber; Christian Peschel
Interferon-alpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes.
Blood 1996;87(11):4731-6.
1996: Walter Aulitzky; Andreas Neubauer; Karin Kolbe; Folker Schneller; C Busemann; E Schleiermacher; Christian Peschel; W Siegert; Christoph Huber; Dieter Huhn
Preliminary results of stem cell mobilization in chronic myeloid leukemia with a moderate intensity chemotherapy regimen and G-CSF or G-CSF plus IL-3.
Bone marrow transplantation 1996;17 Suppl 3():S67-9.
1996: Klaus Geissler; Christian Peschel; Dietger Niederwieser; Herbert Strobl; J Goldschmitt; Leopold Ohler; P Bettelheim; P Kahls; Christoph Huber; Klaus Lechner; Paul Höcker; Karin Kolbe
Potentiation of granulocyte colony-stimulating factor-induced mobilization of circulating progenitor cells by seven-day pretreatment with interleukin-3.
Blood 1996;87(7):2732-9.
1996: Thomas Fischer; J Aman; H van der Kuip; G Rudolf; Christian Peschel; Walter Aulitzky; Christoph Huber
Induction of interferon regulatory factors 2'-5' oligoadenylate synthetase, P68 kinase and RNase L in chronic myelogenous leukaemia cells and its relationship to clinical responsiveness.
British journal of haematology 1996;92(3):595-603.
1996: T Albrecht; R Schwab; Christian Peschel; H J Engels; Thomas Fischer; Christoph Huber; Walter Aulitzky
Cationic lipid mediated transfer of c-abl and bcr antisense oligonucleotides to immature normal myeloid cells: uptake, biological effects and modulation of gene expression.
Annals of hematology 1996;72(2):73-9.
1995: R Schwab; Christian Peschel; D Desprès; G Derigs; Thomas Fischer; Christoph Huber; Walter Aulitzky
Deficient cell cycle control in myeloid cells of patients with newly diagnosed chronic myeloid leukemia.
Cytokines and molecular therapy 1995;1(4):281-8.
1995: Martin Schuler; Walter Aulitzky; Folker Schneller; Christian Peschel; Christoph Huber
[Interferon-alpha in therapy of malignant hemoblastoses].
Der Internist 1995;36(12):1133-8.
1995: D Després; J Goldschmitt; Walter Aulitzky; Christoph Huber; Christian Peschel
Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors.
Experimental hematology 1995;23(14):1431-8.
1995: Klaus Geissler; Christian Peschel; Dietger Niederwieser; J Goldschmitt; F Hladik; A Fritz; Leopold Ohler; P Bettelheim; Christoph Huber; Klaus Lechner
Effect of interleukin-3 pretreatment on granulocyte/macrophage colony-stimulating factor induced mobilization of circulating haemopoietic progenitor cells.
British journal of haematology 1995;91(2):299-305.
1995: H Schönbohn; Martin Schuler; Karin Kolbe; Christian Peschel; Christoph Huber; W Bemb; Walter Aulitzky
Plasma levels of IL-1, TNF alpha, IL-6, IL-8, G-CSF, and IL1-RA during febrile neutropenia: results of a prospective study in patients undergoing chemotherapy for acute myelogenous leukemia.
Annals of hematology 1995;71(4):161-8.
1995: G Göllner; M J Aman; Hans-Peter Steffens; Christoph Huber; Christian Peschel; Hans Günter Derigs
Interferon-alpha (IFN-alpha) inhibits granulocyte-macrophage colony-stimulating factor (GM-CSF) expression at the post-transcriptional level in murine bone marrow stromal cells.
British journal of haematology 1995;91(1):8-14.
1995: Martin Schuler; Christoph Huber; Christian Peschel
Cytokines in the pathophysiology and treatment of chronic B-cell malignancies. A review.
Annals of hematology 1995;71(2):57-63.
1995: T Decker; Thomas Flohr; P Trautmann; M J Aman; W Holter; O Majdic; Christoph Huber; Christian Peschel
Role of accessory cells in cytokine production by T cells in chronic B-cell lymphocytic leukemia.
Blood 1995;86(3):1115-23.
1995: Walter Aulitzky; Christian Peschel; Folker Schneller; Christoph Huber
Biotherapy of chronic myelogenous leukemia.
Annals of hematology 1995;70(3):113-20.
1994: M J Aman; U Keller; G Derigs; M Mohamadzadeh; Christoph Huber; Christian Peschel
Regulation of cytokine expression by interferon-alpha in human bone marrow stromal cells: inhibition of hematopoietic growth factors and induction of interleukin-1 receptor antagonist.
Blood 1994;84(12):4142-50.
1994: Walter Aulitzky; Martin Schuler; Christian Peschel; Christoph Huber
Interleukins. Clinical pharmacology and therapeutic use.
Drugs 1994;48(5):667-77.
1994: U Keller; M J Aman; G Derigs; Christoph Huber; Christian Peschel
Human interleukin-4 enhances stromal cell-dependent hematopoiesis: costimulation with stem cell factor.
Blood 1994;84(7):2189-96.
1994: Christian Peschel; Christoph Huber; Walter Aulitzky
Clinical applications of cytokines.
Presse médicale (Paris, France : 1983) 1994;23(23):1083-91.
1994: Walter E Aulitzky; J Lerche; A Thews; I Lüttichau; N Jacobi; M Herold; W Aulitzky; Christian Peschel; M Stöckle; F Steinbach
Low-dose gamma-interferon therapy is ineffective in renal cell carcinoma patients with large tumour burden.
European journal of cancer (Oxford, England : 1990) 1994;30A(7):940-5.
1993: Walter Aulitzky; Christian Peschel; D Desprès; J Aman; P Trautman; Herbert Tilg; G Rudolf; H Hüttmann; J Obermeier; M Herold
Divergent in vivo and in vitro antileukemic activity of recombinant interferon beta in patients with chronic-phase chronic myelogenous leukemia.
Annals of hematology 1993;67(5):205-11.
1993: M J Aman; G Rudolf; J Goldschmitt; Walter Aulitzky; C Lam; Christoph Huber; Christian Peschel
Type-I interferons are potent inhibitors of interleukin-8 production in hematopoietic and bone marrow stromal cells.
Blood 1993;82(8):2371-8.
1993: F Hladik; Karin Kolbe; Eveline U Irschick; M J Aman; G Gerken; Lothar Färber; E Liehl; Christian Peschel; Walter Aulitzky; Christoph Huber
IL-2, IL-3, and IFN-gamma differently affect in vivo frequencies of circulating precursors of cytotoxic T lymphocytes (CTL-P).
Annals of hematology 1993;67(2):67-74.
1993: Christian Peschel; M J Aman; G Rudolf; Walter Aulitzky; Christoph Huber
Regulation of the cytokine network by interferon: a potential mechanism of interferon in chronic myelogenous leukemia.
Seminars in hematology 1993;30(3 Suppl 3):28-31.
1993: Walter Aulitzky; D Després; G Rudolf; J Aman; Christian Peschel; Christoph Huber
Recombinant interferon beta in chronic myelogenous leukemia.
Seminars in hematology 1993;30(3 Suppl 3):14-6.